Home > Insider Trading > Filing (0001437749-20-016560)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1384101	Veracyte Inc.	VCYT	Services-Medical Laboratories (8071)	205455398

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1769333	C Giulia Kennedy	6000 Shoreline Court Suite 300 South San Francisco CA 94080	Chief Scientific & Med Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2020-07-31	20,000	$20.21	100,487	No	4	M	Direct
Common Stock	Disposition	2020-07-31	20,000	$35.33	80,487	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Disposition	2020-07-31	20,000	$0.00	20,000	$20.21

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
40,000		2029-02-27	No	4	M	Direct

Footnotes

The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 12, 2020.
Represents weighted average sales price. Sale prices for the transactions range from $35.21 to $35.78. Detailed information regarding the number of shares sold at each separate price will be provided to theSEC, the issuer or a shareholder upon request.
The option becomes exercisable as to 25% of the shares on February 28, 2020, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuousservice thereafter.